Barclays analyst Andrew Mok initiated coverage of Privia Health with an Equal Weight rating and $22 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PRVA:
- Privia Health price target lowered to $26 from $30 at TD Cowen
- Privia Health sees FY24 GAAP revenue down 3.5% to up 1% to $1.6B-$1.68B
- Privia Health reports Q4 non-GAAP EPS 15c, consensus 4c
- Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results
- Notable companies reporting before tomorrow’s open
